The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 28, 2025
Filed:
Jan. 22, 2025
Applicant:
Supernus Pharmaceuticals, Inc., Rockville, MD (US);
Inventors:
Gary L. Olson, Mountainside, NJ (US);
Bhaskara Rao Nallaganchu, Hillsborough, NJ (US);
Yanjun Sun, Kendall Park, NJ (US);
Assignee:
Supernus Pharmaceuticals, Inc., Rockville, MD (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 487/04 (2006.01); A61K 31/4178 (2006.01); A61K 31/4188 (2006.01); A61K 31/496 (2006.01); C07D 233/14 (2006.01); C07D 403/06 (2006.01); C07D 405/06 (2006.01);
U.S. Cl.
CPC ...
C07D 487/04 (2013.01); A61K 31/4178 (2013.01); A61K 31/4188 (2013.01); A61K 31/496 (2013.01); C07D 233/14 (2013.01); C07D 403/06 (2013.01); C07D 405/06 (2013.01);
Abstract
Provided are substituted derivatives of 5-(4-chlorophenyl)-2,3-dihydroimidazo[1,2-b]isoindol-5-ol having Formula (I): as well as their stereoisomers and their pharmaceutically acceptable salts. Such substituted derivatives may be used, for example, in pharmaceutical compositions for the treatment of central nervous system diseases or disorders. In addition, methods of making such substituted derivatives are also provided.